Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Dare Bioscience, Inc. (DARE) had Free Cash Flow per Share of $-1.23 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$-0.02M |
|
$-4.02M |
|
-- |
|
$-0.02M |
|
$3.81M |
|
$-3.83M |
|
$-0.19M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-3.83M |
|
$-3.37M |
|
8.87M |
|
8.87M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$6.60M |
|
$1.65M |
|
$6.38M |
|
$12.98M |
|
$19.22M |
|
$0.16M |
|
$6.49M |
|
$25.71M |
|
$-12.73M |
|
$-12.73M |
|
$-12.73M |
|
9.03M |
|
| Cash Flow Statement Financials | |
$-10.89M |
|
$-0.00M |
|
$0.20M |
|
$16.00M |
|
$5.33M |
|
$-10.66M |
|
$0.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.34 |
|
-- |
|
-- |
|
-0.01 |
|
-0.16 |
|
100.00% |
|
18079.54% |
|
18079.54% |
|
-- |
|
18970.73% |
|
18970.73% |
|
$-10.89M |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
-- |
|
-0.11 |
|
-799.66 |
|
31.54% |
|
31.54% |
|
-30.94% |
|
31.96% |
|
$-1.41 |
|
|
Free Cash Flow per Share |
$-1.23 |
$-1.23 |
|